ADC startup ProfoundBio, led by Seagen veterans, raises $112M
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Tae Han. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEATTLE, November 02, 2023--ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for cancer, today announced the addition of multiple industry veterans to its leadership team to support its growth.